Viewing Study NCT06347081



Ignite Creation Date: 2024-05-06 @ 8:20 PM
Last Modification Date: 2024-10-26 @ 3:25 PM
Study NCT ID: NCT06347081
Status: COMPLETED
Last Update Posted: 2024-04-04
First Post: 2024-03-27

Brief Title: Effect of Nd-YAG Laser on Hypertrophic Scar
Sponsor: Cairo University
Organization: Cairo University

Study Overview

Official Title: Efficacy of a Long-Pulsed 1064 nm NdYAG Laser Neodymium-doped Yttrium Aluminium Garnet for Hypertrophic Scars A Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Nd-YAG
Brief Summary: A hypertrophic scar is a serious health concern in the industrialized world Two groups of patients were treated with standard medical care The experimental group received additional laser therapy scar assessment was measured immediately before treatment after 3 and 7 months

T test for comparison before-treatment between the control and study groups ANOVA with repeated measures test for comparison among other measures
Detailed Description: Background A hypertrophic scar is a serious health concern in the industrialized world Objective The impact of this study was to investigate the effect of the Nd-YAG laser at 532nm wavelength on hypertrophic scars Patients and methods Forty male and female patients with hypertrophic scars ranging in age from fifteen to forty-five were recruited from the burn patients clinic within the Faculty of Physical Therapy Cairo University for this study They were randomized into two equivalent groups Group A the control group consisted of 20 patients who were given standard medical care nursing physiotherapy and a sham laser during the course of treatment In contrast Group B the study group consisted of 20 patients who were given 532 nm laser radiation in addition to standard medical care nursing and physiotherapy Treatment was conducted every 2 weeks for 14 sessions Outcome measures included Vancouver Scar Scale score and scar volume The assessment procedures were applied before the initiation of treatment Pre after 3 months Post1 and after 7 months Post 2 from the beginning of the treatment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None